
Chemical Engineering Journal Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100669 - 100669
Published: Oct. 1, 2024
Language: Английский
Chemical Engineering Journal Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100669 - 100669
Published: Oct. 1, 2024
Language: Английский
Science China Materials, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 20, 2025
Language: Английский
Citations
1Ceramics International, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0Journal of Materials Chemistry B, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Protein luminescent crystals that can stably exist in water and ethanol are prepared by a two-step method respond to different concentrations of amino acids.
Language: Английский
Citations
0Ceramics International, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Citations
0Macromolecular Rapid Communications, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 22, 2025
Abstract The development of multifunctional nanotheranostic platforms with stimuli‐responsive capabilities holds significant potential for enhancing cancer diagnosis and treatment. Herein, a glutathione (GSH)‐responsive semiconducting polymer (SP) system, SP/DOX‐SS‐PEG nanoparticles (NPs), is presented, designed combined near‐infrared II (NIR‐II) fluorescence imaging (FI) chemo‐photothermal therapy. amphiphilic SP (SP‐SS‐PEG) synthesized through multi‐step reaction sequence, including Suzuki coupling, amidation, thiol‐disulfide exchange reactions, subsequently encapsulates the anticancer drug doxorubicin (DOX) self‐assembly, resulting in formation GSH‐responsive NPs. These NPs exhibit high photothermal stability GSH‐triggered DOX release. In vitro studies demonstrate that display enhanced cellular uptake robust cytotoxicity against 4T1 cells under 808 nm laser irradiation. Upon intravenous injection tumor‐bearing mice, NIR‐II FI reveals efficient tumor accumulation prolonged retention vivo anti‐tumor efficacy indicate irradiation achieve most inhibition growth, minimal systemic toxicity. Taken together, these findings highlight promising as platform precision theranostics, integrating imaging, release, dual
Language: Английский
Citations
0Journal of Luminescence, Journal Year: 2025, Volume and Issue: unknown, P. 121216 - 121216
Published: March 1, 2025
Language: Английский
Citations
0Advanced NanoBiomed Research, Journal Year: 2025, Volume and Issue: unknown
Published: March 27, 2025
Lanthanide‐based luminescence nanothermometry has demonstrated unprecedented advantages in the development of nanotheranostic platforms for potential medical applications, yet despite exponential research progress and great enthusiasm across various related disciplines, a swift bench‐to‐bedside translation seems to be still out reach. This is predominantly fundamental issues at preclinical stage, such as complex nanomaterials design, incomplete optimization, fragmented characterization, insufficient validation nanothermometer performance physiological environments. The main impediments currently are important biophysicochemical that must addressed comprehensively, first foremost available vitro systems, before going on vivo investigations. review outlines critical perspective, well route suggestions underexplored aspects address significantly minimize existing translational gap.
Language: Английский
Citations
0Engineering materials, Journal Year: 2025, Volume and Issue: unknown, P. 351 - 389
Published: Jan. 1, 2025
Language: Английский
Citations
0Advanced Science, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 30, 2024
Abstract Applying the orthogonal principle for distinguishable second near‐infrared (NIR‐II) emissions has brought new dimensions ratio fluorescence imaging (RFI) detection and information encryption, deepening tissue depth improving signal‐to‐noise security. However, NIR‐II underlying these advanced optical applications have been reported only in heterogeneous structures mixtures, limiting their practicality potential impact. Herein, NIR‐I‐activated NIR‐IIb/c (1530/1825 nm) nanoparticles (ONNPs) are developed by spatially separated doping of Tm 3+ Er emitter upon switching 808 980 nm excitations. RFI techniques emission ONNPs used to demonstrate vessel based on wavelength‐dependent attenuation properties tissue. The superiority coding encoding process a 4 × 1 binary matrix is demonstrated anticounterfeiting decryption quick‐response (QR) code storage. research progress this probe will drive development biomedical sensing, safety, future biophotonics technologies.
Language: Английский
Citations
3Nanoscale, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
Achieving accurate and efficient tumor imaging is crucial in the field of treatment, as it facilitates early detection precise localization tissues, thereby informing therapeutic strategies surgical interventions. The optical technology within second near-infrared (NIR-II) window has garnered significant interest for its remarkable benefits, such enhanced tissue penetration depth, superior signal-to-background ratio (SBR), minimal autofluorescence, reduced photon attenuation, lower scattering. This review explained design optimization nano-agents responsive to NIR-II window, single-walled carbon nanotubes, quantum dots, lanthanum-based nanomaterials, noble metal nanomaterials. These enable non-invasive, deep-tissue with high spatial resolution their properties significantly improve accuracy, efficiency, versatility imaging-guided treatments. And we discussed characteristics advantages fluorescence (FL)/photoacoustic (PA) providing a comprehensive overview latest research progress different FL/PA therapy. Furthermore, exhaustively reviewed applications multifunctional nano-phototherapy technologies carried out by light including photothermal therapy (PTT), photodynamic (PDT), combined modalities like photothermal-chemodynamic (PTT-CDT), photothermal-chemotherapy (PTT-CT), photothermal- immunotherapy (PTT-IO). integrated approaches have gradually matured over past decade are expected become safe effective non-invasive treatment. Finally, outlined prospects challenges development innovation diagnosis nanoplatform. aims provide insightful perspectives future advancements treatment platforms.
Language: Английский
Citations
0